We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 04 Feb 2025

Sysmex (Kobe, Japan) is participating at Medlab Middle East 2025 as a platinum sponsor where the company is showcasing its latest laboratory innovations and technologies and also hosting workshops. More...

At the 2025 edition of Medlab Middle East, Sysmex is highlighting BloodScience Workcell, its novel laboratory automation concept which smartly combines hematology and hemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. BloodScience Workcell consolidates the workflow automation of EDTA and citrate blood sample tubes by combining hematology automation lines, XR-9000 or XN-9100, with the new CN track for hemostasis. Also featured is the UN-Series of urinalysis solutions which can automate a lab’s urinalysis work area according to required workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit and a secure investment.

Sysmex is also showcasing its comprehensive line of IVD flow cytometry products, headlined by the advanced PS-10 sample preparation system and the XF-1600 flow cytometer, in addition to an extensive portfolio of monoclonal antibodies and consumables. Sysmex is demonstrating CyFlow WA, its innovative Work Area Manager (WAM) software, which is the key to a smartly connected modern clinical flow cytometry lab. It integrates seamlessly with existing Sysmex lab equipment, acting as a powerful middleware solution bridging hematology and clinical flow cytometry data analysis.

Among its other solutions, Sysmex is showcasing HISCL-800, the latest addition to its HISCL family of automated immunoassay systems. The unique features of HISCL-800 include fast reaction time with throughput of up to 100 tests per hour, delivering highly sensitive and specific clinical results with small footprint, making it an ideal partner for small and medium-sized laboratories. With a fast reaction time for every parameter, it takes 17 mins to get the first test result. The HISCL-800’s rapid analysis enables laboratories to meet their reporting objectives, especially for STAT samples. Visitors to the Sysmex booth can also view digital displays of its cancer diagnostic solutions for breast cancer and colorectal cancer.


New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.